Company Overview
Provision of veterinary products and services to production and companion animals.
Website | www.apiam.com.au |
---|---|
Head Office | East Bendigo VIC |
Registry | Boardroom Pty Limited |
CEO | Christopher Richards |
Chair Person | Andrew Vizard |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Services |
Sector | Health Care |
Market Cap | $100 m |
---|---|
Shares on Issue | 180 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Professor Andrew Lancelot Vizard
Non-Executive Chairman,Non-Executive Director 05/11/2015
Prof Vizard is a Principal Fellow at the Faculty of Veterinary and Agricultural Sciences, University of Melbourne and previously Associate Prof of Veterinary Epidemiology and Director of The Mackinnon Project, a recognised leader in sheep and beef veterinary consultancy. An experienced company director, he has previously held directorships in ASX companies, statutory bodies and research organisations including Animal Health Australia, the body responsible for coordinating Australia's animal health system; Primesafe, the statutory authority responsible for regulating the production of safe meat in Victoria; and the Australian Wool Corporation. He is currently Chair of the Vizard Foundation and Executive Secretary for the Hermon Slade Foundation and the Australia & Pacific Science Foundation
BVSc(Hons), MVPM, FAICD Male
Mr Richard (Rick) John Dennis
Non-Executive Director 05/11/2015
Mr Dennis held a number of senior roles for over 35 years with Ernst & Young (EY) and was the Managing Partner of EYs Queensland practice on two occasions from 2001-2007 and from 2014-15. Mr Dennis also held a number of executive management roles at EY, including Deputy COO and CFO for the AsiaPacific practice where he was responsible for overseeing the financial and operational integration of EYs Australian and Asian member firms. Mr Dennis is a member of Australian Super's Queensland Advisory Board, a member of the Advisory Boards of EWM Group and HLB Chessboard, and an external member of the Audit & Risk Committee of Racing Queensland. He is also a non-executive director of Open Minds and ASX-listed Motorcycle Holdings Limited and ASX-listed Cettire Limited
BCom, LLB, CA, MAICD Chartered Accountant Male
Mr Michael van Blommestein
Non-Executive Director 05/11/2015
Mr Blommestein was a Vice President and Country Manager of Australia and New Zealand for Zoetis and managed the spin-off of Zoetis from Pfizer Australia. Mr Blommestein is an experienced director in the animal health sector. He presided over Animal Medicines Australia, the peak industry body for five years and was a member of the board for nearly a decade. Mr Blommestein played an integral role in leading and overseeing the transition of Animal Health Alliance into Animal Medicines Australia and has also served on the board of Animal Health Association Japan.
GAICD, 1stClassDip-AgriSci, CertMktng, StratMgmtRe Male
Dr Christopher Irwin Richards
Managing Director 25/03/2015
Dr Richards is the Managing Director of ASX listed Apiam Animal Health Ltd, as well as the Australian subsidiary entities and joint venture companies, which provide veterinary services to Australian regional and rural communities. Mr Richards is also a Director of registered charity, Fur Life Foundation Ltd, which raises funds to support people in rural, regional, and remote communities Mr Richards is also a Director of Apiam Solutions LLC, a JV company based in the USA that provides product solutions to the Northern American production animal industries. Mr Richards is responsible for the strategic direction of Apiam, which has seen the develop, grow, acquire and integrate production and companion animal veterinary clinics, veterinary wholesale, logistics, laboratory and genetics services businesses since 1998 into the Apiam of today. Mr Richards is a member of Australian Pork Limited's Biosecurity Strategic Review Panel and ASF Advisory Group.
BSc, BVSc, MAICD Male
Professor Jan Tennent
Non-Executive Director 01/08/2018
Mr Tennent is a Fellow of the Australian Academy of Technology and Engineering and the Australian Society for Microbiology and, a Principal Fellow at the University of Melbourne. She is an internationally recognised researcher with specialist knowledge of antimicrobial resistance mechanisms and the discovery and commercialisation of vaccines. Mr Tennent has held senior roles at CSIRO, CSL, and Pfizer Animal Health where she was the Director of Business Development and Global Alliances in the APAC region. Her most recent executive management role was CEO of Biomedical Research Victoria (2012-2019). Mr Tennent is also a non-executive director of AusBiotech Limited and eviDent Foundation Limited.
PhD(Philosophy), BSc(Hons),FASM, GAICD, GCertMgt, Female
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | Cjoea Family Company Pty Ltd <Richards Familya/C> | 30,219,451 | 22.60 |
2. | Petstock Investments Pty Ltd | 21,240,500 | 15.88 |
3. | Citicorp Nominees Pty Limited | 5,852,675 | 4.38 |
4. | Cs Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C> | 3,008,926 | 2.25 |
5. | Scolexia Commodity Pty Ltd | 2,755,777 | 2.06 |
6. | Donald Crosby & Sharron Crosby <D & S Crosby Family A/C> | 2,207,506 | 1.65 |
7. | Certane Ct Pty Ltd <Apiam Animal Est Unallo Ac> | 2,139,938 | 1.60 |
8. | Cobash Pty Limited <J & S Wright Family A/C> | 1,872,006 | 1.40 |
9. | Hamilton Animal Health Pty Ltd | 1,564,270 | 1.17 |
10. | HSBC Custody Nominees (Australia) Limited | 1,409,907 | 1.05 |
11. | Four Post Investments Pty Ltd <Johnstone Investment A/C> | 1,386,700 | 1.04 |
12. | Mr Lincoln O'Meara | 1,377,888 | 1.03 |
13. | Aileen Mary Vanderfeen | 1,377,888 | 1.03 |
14. | Rachel Louise O'Meara | 1,377,888 | 1.03 |
15. | Mr Roger Charles Carmody & Mrs Maris Moore Carmody <R & M Carmody A/C> | 1,258,650 | 0.94 |
16. | Mrs Kate Judith Malin <Howison Family A/C> | 1,229,161 | 0.92 |
17. | Sonjaswright Pty Limited | 1,211,846 | 0.91 |
18. | David Frith Pty Ltd <Frith Family A/C> | 1,104,909 | 0.83 |
19. | Mr Neil Leighton & Mrs Helen Leighton <Leighton Super Fund A/C> | 1,104,131 | 0.83 |
20. | Cindy Jane Pty Ltd <Cindy Jane Family A/C> | 1,045,701 | 0.78 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
06/09/2021 | Christopher Richards | 31,000 | $30,535 | Buy | On-market trade. |
04/05/2021 | Christopher Richards | 50,000 | $45,125 | Buy | On-market trade. |
23/04/2021 | Jan Tennent | 843 | $682 | Buy | Dividend Reinvestment Plan (DRP). |
23/04/2021 | Christopher Richards | 451,696 | $365,693 | Buy | Dividend Reinvestment Plan (DRP). |
23/04/2021 | Christopher Richards | 1,859 | $1,505 | Buy | Dividend Reinvestment Plan (DRP). |
23/04/2021 | Andrew Vizard | 3,350 | $2,712 | Buy | Dividend Reinvestment Plan (DRP). As per announcement on 23/04/2021. |
23/04/2021 | Richard (Rick) Dennis | 327 | $264 | Buy | Dividend Reinvestment Plan (DRP). |
23/04/2021 | Michael van Blommestein | 1,582 | $1,280 | Buy | Dividend Reinvestment Plan (DRP). |
21/04/2021 | Christopher Richards | 296,445 | $252,163 | Buy | On-market trade. |
06/11/2020 | Christopher Richards | 15,206 | $10,483 | Buy | On-market trade. |
30/10/2020 | Christopher Richards | 82,714 | $55,418 | Expiry | As advised by the company. 165,430 - Performance Rights Expiry of Performance Rights |
23/10/2020 | Andrew Vizard | 4,321 | $2,660 | Buy | Dividend Reinvestment Plan (DRP). |
23/10/2020 | Christopher Richards | 584,794 | $359,999 | Buy | Dividend Reinvestment Plan (DRP). |
23/10/2020 | Michael van Blommestein | 2,041 | $1,256 | Buy | Dividend Reinvestment Plan (DRP). |
23/10/2020 | Richard (Rick) Dennis | 421 | $259 | Buy | Dividend Reinvestment Plan (DRP). |
23/10/2020 | Jan Tennent | 706 | $434 | Buy | Dividend Reinvestment Plan (DRP). |